Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Surrozen, Inc./DE Director's Dealing 2021

Aug 17, 2021

34164_dirs_2021-08-16_c0ec9434-a1ec-4198-bacb-1d74cad58c56.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Surrozen, Inc./DE (SRZN)
CIK: 0001824893
Period of Report: 2021-08-11

Reporting Person: Parker Craig C (Director, Chief Executive Officer)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Employee Stock Option (right to buy) $0.12 2028-04-10 Common Stock (316167) Direct
Employee Stock Option (right to buy) $0.22 2028-12-31 Common Stock (35129) Direct
Employee Stock Option (right to buy) $1.89 2031-02-22 Common Stock (351297) Direct

Footnotes

F1: Twenty-five percent of the shares subject to the Stock Option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.

F2: Received pursuant to the Business Combination Agreement (the "BCA"), dated April 15, 2021, by and among the Issuer (fka "Consonance-HFW Acquisition Corp"), Perseverance Merger Sub Inc. ("Merger Sub"), and Surrozen, Inc. (the "Original Surrozen"). Under the terms of the BCA, among other things, Merger Sub merged with and into the Original Surrozen, with Original Surrozen surviving as a wholly-owned subsidiary of the Issuer (the "Business Combination"), the Original Surrozen changed its name to Surrozen Operating, Inc., and the Issuer changed its name to Surrozen, Inc. In addition, per the terms of the BCA, each share and equity award of the Original Surrozen outstanding as of effective time of the Business Combination was exchanged for shares of the Issuer's Common Stock or comparable equity awards that are settled or are exercisable for shares of the Issuer's Common Stock, as applicable, at the exchange ratio of 0.175648535.

F3: 1/48th of the shares subject to the Stock Option vests on each monthly anniversary of the vesting commencement date over a four-year period.